electroCore (ECOR) Finished Goods (2017 - 2026)
electroCore's quarterly Finished Goods came in at $567000.0 in Q1 2026, up 30.95% year-on-year from $433000.0 in Q1 2025, and up 94.85% quarter-over-quarter from $291000.0 in Q4 2025.
electroCore has reported Finished Goods for 6 years, with the latest figure at $567000.0 in Q1 2026.
- For the quarter ending Q1 2026, Finished Goods rose 30.95% year-over-year to $567000.0; the trailing twelve-month figure through Mar 2026 stood at $567000.0 (up 30.95% YoY), and the FY2025 full-year result was $291000.0, down 48.04% from the prior year.
- Finished Goods for Q1 2026 stood at $567000.0, up from $291000.0 in the prior quarter.
- The five-year high for Finished Goods was $602000.0 in Q3 2025, with the low at $291000.0 in Q4 2025.
- Average Finished Goods over 3 years is $473666.7, with a median of $496500.0 recorded in 2024.
- Year-over-year, Finished Goods plunged 48.04% in 2025 and surged 30.95% in 2026.
- Tracing ECOR's Finished Goods over 3 years: stood at $560000.0 in 2024, then sank by 48.04% to $291000.0 in 2025, then soared by 94.85% to $567000.0 in 2026.
- The last three Finished Goods figures came in at $567000.0 (Q1 2026), $291000.0 (Q4 2025), and $602000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 567,000.00 |
| Dec 31, 2025 | 291,000.00 |
| Sep 30, 2025 | 602,000.00 |
| Jun 30, 2025 | 389,000.00 |
| Mar 31, 2025 | 433,000.00 |
| Dec 31, 2024 | 560,000.00 |
| Jun 30, 2019 | 396,386.00 |
| Mar 31, 2019 | 451,916.00 |
| Dec 31, 2018 | 176,003.00 |
| Sep 30, 2018 | 295,121.00 |
| Jun 30, 2018 | 323,035.00 |
| Dec 31, 2017 | 193,763.00 |